News
H&R Block Q4 Earnings Call Highlights
H&R Block NYSE: HRB reported fiscal 2026 revenue growth of 4.9% and adjusted earnings-per-share growth of 13.9%, as the tax-preparation company cited improved client conversion, retention and demand f
Energy Vault Q2 Earnings Call Highlights
Energy Vault NYSE: NRGV reported second-quarter 2026 revenue of $17.4 million, up 104% from $8.5 million a year earlier, as progress on Australian projects supported results. The energy-storage and po
Owlet Q2 Earnings Call Highlights
Owlet NYSE: OWLT reported record second-quarter revenue as growth in its connected baby-monitoring products, international markets and subscription business helped offset promotional pressure in the c
SES AI Q2 Earnings Call Highlights
SES AI NYSE: SES reported second-quarter 2026 revenue of $5.1 million, up more than 40% from $3.5 million in the prior-year quarter, while reaffirming full-year revenue guidance of $30 million to $35
AtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel Growth
AtriCure NASDAQ: ATRC said it is seeing continued growth across its atrial fibrillation, left atrial appendage management and postsurgical pain-management businesses, supported by new product adoption
National CineMedia, Inc. (NCMI) Q2 2026 Earnings Call Transcript
National CineMedia, Inc. (NCMI) Q2 2026 Earnings Call Transcript
Super Micro Computer, Inc. (SMCI) Q4 2026 Earnings Call Transcript
Super Micro Computer, Inc. (SMCI) Q4 2026 Earnings Call Transcript
Taysha Gene Therapies, Inc. (TSHA) Q2 2026 Earnings Call Transcript
Taysha Gene Therapies, Inc. (TSHA) Q2 2026 Earnings Call Transcript
C.H. Robinson Worldwide, Inc. (CHRW) Presents at Deutsche Bank's Chicago Industrials Summit Transcript
C.H. Robinson Worldwide, Inc. (CHRW) Presents at Deutsche Bank's Chicago Industrials Summit Transcript
Bravura Solutions Limited (BVSFF) Q4 2026 Earnings Call Transcript
Bravura Solutions Limited (BVSFF) Q4 2026 Earnings Call Transcript
Target Appoints Lowe's Veteran Chandhu Nair as First Chief AI Officer
Target has appointed its first chief artificial intelligence officer, the company said in a Tuesday (Aug. 11) article. Chandhu Nair will join the company on Aug. 24 and will bring greater focus and co
Aramark's Surge Necessitates A Prudent Downgrade
Aramark delivered strong Q3 results, with revenue and adjusted EPS exceeding analyst expectations and robust growth across both U.S. and international segments. ARMK forecasts full-year organic revenu
Snail, Inc. (SNAL) Q2 2026 Earnings Call Transcript
Snail, Inc. (SNAL) Q2 2026 Earnings Call Transcript
Mobile Infrastructure Corporation (BEEP) Q2 2026 Earnings Call Transcript
Mobile Infrastructure Corporation (BEEP) Q2 2026 Earnings Call Transcript
High Roller Technologies, Inc. (ROLR) Q2 2026 Earnings Call Transcript
High Roller Technologies, Inc. (ROLR) Q2 2026 Earnings Call Transcript
Adamera Upsizes Previously Announced Non-Brokered Private Placement to $785,000
Vancouver, British Columbia – TheNewswire - August 11, 2026 – Adamera Minerals Corp. (TSX-V: ADZ; OTC: DDNFF) ("Adamera" or the "Company") is pleased to announce that, further to its press release of
Seer Q2 Earnings Call Highlights
Seer NASDAQ: SEER reported second-quarter revenue of $3.1 million, down from $4.1 million a year earlier but up from $2.8 million in the first quarter, as the proteomics company cited continued pressu
Super Micro Computer Q4 Earnings Call Highlights
Super Micro Computer NASDAQ: SMCI reported record fiscal 2026 revenue of $39.1 billion, up 78% from $22 billion in fiscal 2025, as demand for artificial intelligence infrastructure continued to drive
TransAct Technologies Q2 Earnings Call Highlights
TransAct Technologies NASDAQ: TACT reported second-quarter net sales of $13.9 million, up slightly from $13.8 million a year earlier, as growth in its food service technology business was partially of
Taysha Gene Therapies Q2 Earnings Call Highlights
Taysha Gene Therapies NASDAQ: TSHA said it completed dosing in its REVEAL pivotal trial and ASPIRE trial for TSHA-102, its gene therapy candidate for Rett syndrome, while preparing for a potential bio
